With a new study showing the PSA test reduces the prostate cancer death rate by 44 percent, ZERO The Project to End Prostate Cancer demands an apology for all at risk of the disease from the American Cancer Society, which has long discounted the importance of prostate cancer testing. “It’s time to ‘Man Up’ and [...]
No Comments »
Filed under: Men's Health
Endo Pharmaceuticals (Nasdaq: ENDP) has submitted a complete response to the U.S. Food and Drug Administration (FDA) following the company’s receipt of a Complete Response letter in October 2009 related to the New Drug Application (NDA) submission for FORTESTA™ (testosterone) 2% gel…
No Comments »
Filed under: Men's Health
Catalan researchers have studied the socioeconomic and health inequalities experienced by people over the age of 64. The results of the study show that women live longer, but experience more limitations to daily activity (53%) and a lower quality of life than men of the same age (30%)…
No Comments »
Filed under: Women's Health
American Medical Systems® (AMS) (Nasdaq: AMMD), a leading provider of world-class devices and therapies for both male and female pelvic health, announced the Food and Drug Administration (FDA) has cleared the MiniArc® Precise Single-Incision Sling System, a product for the treatment of female stress urinary incontinence (SUI)…
No Comments »
Filed under: Women's Health
WASHINGTON (MedPage Today) — The Centers for Medicare and Medicaid Services (CMS) announced that it will cut reimbursement rates an average of one-third for durable medical equipment (DME) in nine major cities.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA has expanded its Class I recall — the agency’s most serious — for two more LIFEPAK defibrillator models due to power problems that may cause the device not to deliver a lifesaving shock to the heart.
No Comments »
Filed under: General Health News
The manufacturer of a blood culture product (Xpert MRSA/SA BC) is voluntarily recalling several lots after receiving reports of false-negative methicillin-resistant Staphylococcus aureus (MRSA) tests.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA has expanded its Class I recall — the agency’s most serious — for two more LIFEPAK defibrillator models due to power problems that may cause the device not to deliver a lifesaving shock to the heart.
No Comments »
Filed under: Pharmacy News
The manufacturer of a blood culture product (Xpert MRSA/SA BC) is voluntarily recalling several lots after receiving reports of false-negative methicillin-resistant Staphylococcus aureus (MRSA) tests.
No Comments »
Filed under: Pharmacy News
Bristol-Myers Squibb Company and AstraZeneca today announced results up to 76-weeks from a Phase 3 study of ONGLYZA(TM) (saxagliptin) as initial combination therapy with metformin, which produced long-term glycemic improvement (as measured by glycosylated hemoglobin level (HbA1c)) in treatment-naive adults with type 2 diabetes mellitus inadequately controlled on diet and exercise compared to treatment with [...]
No Comments »
Filed under: Pharmacy News
